Twinbeech Capital LP Zai Lab LTD Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $372,232 - $562,593	10,884 New	10,884 $372,000
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $129,796 - $301,005	-4,674 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $60,719 - $116,362	-1,106 Reduced 19.13%	4,674 $294,000
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $606,900 - $1.03 Million	5,780 New	5,780 $609,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.75B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.